Combining bioactivity and affinity to design of positive allosteric modulators of the metabotropic glutamate receptor using 3D-QSAR

References

• Cid, J. M., Tresadern, G., Vega, J. A., de Lucas, A. I., Matesanz, E., Iturrino, L., … Trabanco, A. A. (2012). Discovery of 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): A positive allosteric modulator of the metabotropic glutamate 2 receptor. Journal of Medicinal Chemistry, 55(20), 8770–8789. doi: 10.1021/jm3010724
   PubMed Web of Science ®Google Scholar
• Cid, J. M., Tresadern, G., Vega, J. A., de Lucas, A. I., Cerro, A. D., Matesanz, E., … Trabanco, A. A. (2016). Discovery of 8-trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a selective and orally bioavailable mGlu2 receptor positive allosteric modulator (PAM). Journal of Medicinal Chemistry, 59(18), 8495–8507. doi: 10.1021/acs.jmedchem.6b00913
   PubMed Web of Science ®Google Scholar
• Doornbos, M. L. J., Wang, X., Vermond, S. C., Peeters, L., Perez-Benito, L., Trabanco, A. A., … IJzerman, A. P. (2019). Covalent allosteric probe for the metabotropic glutamate receptor 2: Design, synthesis, and pharmacological characterization. Journal of Medicinal Chemistry, 62(1), 223–233. doi: 10.1021/acs.jmedchem.8b00051
   PubMed Web of Science ®Google Scholar
• Doornbos, M. L. J., Pérez-Benito, L., Tresadern, G., Mulder-Krieger, T., Biesmans, I., Trabanco, A. A., … Heitman, L. H. (2016). Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222. British Journal of Pharmacology, 173(3), 588–600. doi: 10.1111/bph.13390
   PubMed Web of Science ®Google Scholar
• Doornbos, M. L. J., Cid, J. M., Haubrich, J., Nunes, A., van de Sande, J. W., Vermond, S. C., … Tresadern, G. (2017). Discovery and kinetic profiling of 7-aryl-1,2,4-triazolo[4,3-a]pyridines: Positive allosteric modulators of the metabotropic glutamate receptor 2. Journal of Medicinal Chemistry, 60(15), 6704–6720. doi: 10.1021/acs.jmedchem.7b00669
   PubMed Web of Science ®Google Scholar
• Farinha, A., Lavreysen, H., Peeters, L., Russo, B., Masure, S., Trabanco, A. A., … Tresadern, G. (2015). Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2. British Journal of Pharmacology, 172(9), 2383–2396. doi: 10.1111/bph.13065
   PubMed Web of Science ®Google Scholar
• Ghorab, M. M., Alsaid, M. S., Samir, N., Abdellatif, G. A., Soliman, A. M., Ragab, F. A., & Da, A. E. E. (2017). Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules. European journal of medicinal chemistry, 134, 304. doi: 10.1016/j.ejmech.2017.04.028
   PubMed Web of Science ®Google Scholar
• Li, M. L., Hu, X. Q., Li, F., & Gao, W. J. (2015). Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end? Progress in Neuropsychopharmacology & Biological Psychiatry, 60, 66–76. doi: 10.1016/j.pnpbp.2015.02.012
   PubMed Web of Science ®Google Scholar
• Lundström, L., Bissantz, C., Beck, J., Dellenbach, M., Woltering, T. J., Wichmann, J., & Gatti, S. (2017). Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2. Neuropharmacology, 115, 115–127. doi: 10.1016/j.neuropharm.2016.08.040
   PubMed Web of Science ®Google Scholar
• Niswender, C. M., & Conn, P. J. (2010). Metabotropic glutamate receptors: Physiology, pharmacology, and disease. Annual Review of Pharmacology and Toxicology, 50(1), 295–322. doi: 10.1146/annurev.pharmtox.011008.145533
   PubMedGoogle Scholar
• Perez-Benito, L., Doornbos, M. L. J., Cordomı, A., Peeters, L., Lavreysen, H., Pardo, L., & Tresadern, G. (2017). Molecular switches of allosteric modulation of the metabotropic glutamate 2 receptor. Structure, 25, 1153–1162. doi: 10.1016/j.str.2017.05.021
   PubMed Web of Science ®Google Scholar
• Pingaew, R., Prachayasittikul, V., Mandi, P., Nantasenamat, C., Prachayasittikul, S., Ruchirawat, S., & Prachayasittikul, V. (2015). Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors. Bioorganic & medicinal chemistry, 23, 3472. doi: 10.1016/j.bmc.2015.04.036
   PubMed Web of Science ®Google Scholar
• Sakthivel, S., Alagesan, T., Muthu, S., Abraham, C. S., & Geetha, E. (2018). Quantum mechanical, spectroscopic study (FT-IR and FT-Raman), NBO analysis, HOMO-LUMO, first order hyperpolarizability and docking studies of a non-steroidal anti-inflammatory compound. Journal of Molecular Structure., 1156, 645–656. doi: 10.1016/j.molstruc.2017.12.024
   Web of Science ®Google Scholar
• Shiri, F., Rakhshani-Morad, S., Samzadeh-Kermani, A., & Karimi, P. (2016). Computer-aided molecular design of some indolinone derivatives of PLK4 inhibitors as novel anti-proliferative agents. Medicinal Chemistry Research, 25(11), 2643–2665. doi: 10.1007/s00044-016-1638-3
   Web of Science ®Google Scholar
• Trabanco, A. A., Tresadern, G., Macdonald, G. J., Vega, J. A., de Lucas, A. I., Matesanz, E., … Cid, J. M. (2012). Imidazo[1,2-a]pyridines: Orally active positive allosteric modulators of the metabotropic glutamate 2 receptor. Journal of Medicinal Chemistry, 55(6), 2688–2701. doi: 10.1021/jm201561r
   PubMed Web of Science ®Google Scholar